Cited by

• Distinguishing the effects of systemic CSF1R inhibition by PLX3397 on microglia and peripheral immune cells.

  Okojie AK, Uweru JO, Coburn MA, Li S, Cao-Dao VD, Eyo UB. Okojie AK, et al. J Neuroinflammation. 2023 Oct 21;20(1):242. doi: 10.1186/s12974-023-02924-5. J Neuroinflammation. 2023. PMID: 37865779 Free PMC article.
• Active surveillance and clinical analysis of anaphylaxis based on the China Hospital Pharmacovigilance System.

  Wang C, Li Z, Yu Y, Feng M, Liu A. Wang C, et al. Front Pharmacol. 2023 Jul 11;14:1180685. doi: 10.3389/fphar.2023.1180685. eCollection 2023. Front Pharmacol. 2023. PMID: 37497105 Free PMC article.
• Clinical and experimental treatment of allergic asthma with an emphasis on allergen immunotherapy and its mechanisms.

  Fiala S, Fleit HB. Fiala S, et al. Clin Exp Immunol. 2023 Apr 7;212(1):14-28. doi: 10.1093/cei/uxad031. Clin Exp Immunol. 2023. PMID: 36879430 Free PMC article.
• Interactions between Severe Allergy and Anxiety in Anti-SARS-CoV-2 Vaccinees.

  Asperti C, Benanti G, Ramirez GA, Russo M, Vai B, Bramé B, Viapiana N, Nannipieri S, Cilona MB, Mazzetti M, Zuffada S, Di Mattei VE, Benedetti F, Dagna L, Yacoub MR. Asperti C, et al. Vaccines (Basel). 2022 Nov 30;10(12):2047. doi: 10.3390/vaccines10122047. Vaccines (Basel). 2022. PMID: 36560457 Free PMC article.
• Improving Methods of Identifying Anaphylaxis for Medical Product Safety Surveillance Using Natural Language Processing and Machine Learning.

  Carrell DS, Gruber S, Floyd JS, Bann MA, Cushing-Haugen KL, Johnson RL, Graham V, Cronkite DJ, Hazlehurst BL, Felcher AH, Bejan CA, Kennedy A, Shinde MU, Karami S, Ma Y, Stojanovic D, Zhao Y, Ball R, Nelson JC. Carrell DS, et al. Am J Epidemiol. 2023 Feb 1;192(2):283-295. doi: 10.1093/aje/kwac182. Am J Epidemiol. 2023. PMID: 36331289 Free PMC article.